Navigation Links
Marshall Edwards Announces Private Placement
Date:5/2/2011

SAN DIEGO, May 2, 2011 /PRNewswire/ -- Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today that it has entered into a definitive agreement with certain institutional investors to sell in a private placement common stock and warrants for gross proceeds of up to $4 million, before deducting fees and expenses of the offering, of which approximately $1.1 million would result from the sale of approximately 835,217 shares of common stock at $1.333 per share. The remaining $2.9 million would be subject to the exercise of one-year series B warrants at their initial exercise price of $1.333 per share and the fulfillment or waiver of certain conditions.

The Company will also issue series A warrants which will initially represent the right to purchase up to 626,413 shares of common stock exercisable after six months for a period of five years and subject to proportionate increases to the extent the series B warrants are exercised. Series C warrants may entitle the holders to obtain additional shares of common stock exercisable in the event the trading price of the common stock is below certain levels on specified future dates during a period of up to one year following the closing date.

The offering is expected to close on or about May 13, 2011, subject to certain customary closing conditions as well as the closing of the transactions contemplated by the asset purchase agreement entered into between the Company and its majority shareholder, Novogen Limited, and Novogen Research Pty Limited on December 21, 2010, which is pending approval at a meeting of Novogen shareholders on May 6, 2011.

The net proceeds from the offering will be used primarily to continue development of Marshall Edwards' two lead oncology programs, including a Phase I clinical trial of its intr
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
2. Marshall Edwards Receives Positive Response From NASDAQ
3. Marshall Edwards to Host Annual Meeting of Stockholders
4. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
5. Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells
6. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
7. Edwards Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
8. Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film
9. Esperion Announces Results From Phase 1 Study and Four Preclinical Studies for ETC-1002
10. Regeneron Announces Presentation at the Bank of America Merrill Lynch 2011 Health Care Conference
11. Amira Pharmaceuticals Announces Completion of Phase 1 Clinical Study for AM152, A Novel LPA1 Receptor Antagonist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... available in its catalogue: Global Coatings ... http://www.reportlinker.com/p01375204/Global-Coatings-for-Medical-Devices-Industry.html This report analyzes ... in US$ Million by the following Product Segments: ... Coatings. The report provides separate comprehensive analytics for ...
(Date:8/20/2014)... , Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces ... Ltd., has received Chinese FDA (CFDA) approval and ... Tablets into the China ... and distribution agreement with Sinochem Jiangsu Pharmaceutical Co., ... US FDA approved and China CFDA certified oral ...
(Date:8/20/2014)... Aug. 20, 2014  Glades Drugs, an independent pharmacy chain ... to announce its expansion into a new corporate headquarters in ... an 8,000-square-foot office space and state of the art lab. ... 100 open positions for the new facility. ... will serve as the chain,s corporate headquarters and closed door ...
Breaking Medicine Technology:Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2
... , Jan. 20 Ethicon, Inc., announced ... Inc., following clearance under the Hart-Scott-Rodino Antitrust Improvement Act. ... to designing, developing and commercializing devices that address conditions ... announced its agreement to acquire Acclarent on December ...
... Jan. 20 Medical device maker Smith & Nephew,s (NYSE: ... week more than $2 million in implants and surgical instruments ... week,s earthquake in Haiti . , The donation, set to arrive ... treat bone fractures. , These resources are being distributed in ...
Cached Medicine Technology:Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments 2Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments 3
(Date:8/21/2014)... OpsAssure, the local start-up offering software-as-a-service, ... in the Harbor Accelerator's 14 week development program. ... valuable resources.he Harbor’s goal is to launch innovative ... selected for the program receives a variety of ... grow quickly, test markets and become viable in ...
(Date:8/21/2014)... NY (PRWEB) August 21, 2014 Recently nominated as ... been on quite the journey to be the man he is ... and has always had a positive look on women, respecting them ... top, KC owes gratefulness and thanks to a man who he ... of years, Howard Stern. , KC Armstrong’s name will ring a ...
(Date:8/21/2014)... Recently, BambooIndustry.com, one of the most famous bamboo ... range of hand scraped bamboo floorings to ... Autumn special offer for these elegant items. According to ... discounted price, up to 25% off; the promotion will ... Providing natural looks and available in different varieties, the ...
(Date:8/20/2014)... (PRWEB) August 21, 2014 Top ... many web hosting companies and announced Bluehost ( ... recommended hosting companies that provide high quality PHP ... by Top 10 Best SEO Hosting are unbiased ... receive the best information possible. During the recent ...
(Date:8/20/2014)... 2014 On September 7th, 2014 Peoria will ... connects people living with MS with people who care. This ... are 85% of the way to their goal. This years ... at 11:30 and the walk starts at 1:00 pm. ... answer question about chiropractic care and how it helps symptoms ...
Breaking Medicine News(10 mins):Health News:WRNW1's KC Armstrong Expresses Thanks and Appreciation to Howard Stern 2Health News:Cheap Hand Scraped Bamboo Floorings Recently Unveiled by BambooIndustry.com 2Health News:New Reviews Of Cheap PHP Hosting Companies Unveiled By Top 10 Best SEO Hosting 2Health News:Dr. Kelch of AlignLife North Peoria Supports Peoria Annual Walk MS 2
... has received two grants totaling more than $4.3 million ... neuroscience and pediatric pharmacology and vision research as part ... four academic health centers and the College of Optometry. ... at SUNY Downstate Medical Center in Brooklyn, New York. ...
... (QUT ) School of Nursing and Midwifery, in Brisbane, ... in self-managing their health and emotional concerns. Participants ... for ongoing information and emotional support, compared to those ... "There are a range of post-treatment effects people might ...
... On April 8, 1982, alone in a laboratory, chemist ... an impossible pattern. He had discovered quasicrystals. But ... scientific establishment for years. On October 5, ... What compelled Shechtman to stand by his research? What ...
... -- ,Black and Hispanic children in the United States are ... after they suffer a minor head injury, a new study ... with head injuries treated at 25 pediatric emergency care trauma ... cranial CT scan. There were no significant race/ethnicity-related differences ...
... , FRIDAY, Oct. 14 (HealthDay News) -- One in ... that can spread E. coli, likely because so many people ... new study contends. The findings also suggest that many ... at the London School of Hygiene & Tropical Medicine and ...
... HealthDay Reporter , THURSDAY, Oct. 13 (HealthDay News) -- ... heart disease, continues to fall, according to new research from ... 6 percent of adults had heart disease in 2010, down ... pressure and high cholesterol, as well as declines in smoking, ...
Cached Medicine News:Health News:SUNY receives $4.3 million for research in neuroscience, pediatric pharmacology and vision 2Health News:SUNY receives $4.3 million for research in neuroscience, pediatric pharmacology and vision 3Health News:Nurses boost well-being for cancer survivors 2Health News:How and why did 2011 Nobel winner Dan Shechtman persist despite rejection? 2Health News:1 in 6 Cellphones in Britain Contaminated With 'Fecal Matter' 2Health News:U.S. Heart Disease Rates Keep Falling: CDC 2Health News:U.S. Heart Disease Rates Keep Falling: CDC 3
Straight shafts and serrated handle with polished finish. Teeth: Fine 1 x 2 teeth. Most popular size or model....
Straight shafts with fine Pierse type tips. Flat smooth handle with dull finish....
Titanium. Straight shafts with 6 mm platform and Pierse tips. Flat serrated handle with dull finish....
0.12 mm, 1 x 2 teeth set at 45 degrees with 5 mm tying platform. Serrated handle with polished finish....
Medicine Products: